This list is based on the watchlists of people on Stock Events who follow JNGHF. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Show more...
FAQ
What is Jiangsu Hengrui Pharmaceuticals. stock price today?▼
The current price of JNGHF is $8.1 USD — it has decreased by -6.85% in the past 24 hours. Watch Jiangsu Hengrui Pharmaceuticals. stock price performance more closely on the chart.
What is Jiangsu Hengrui Pharmaceuticals. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Jiangsu Hengrui Pharmaceuticals. stocks are traded under the ticker JNGHF.
When is the next Jiangsu Hengrui Pharmaceuticals. earnings date?▼
Jiangsu Hengrui Pharmaceuticals. is going to release the next earnings report on April 23, 2026.
What were Jiangsu Hengrui Pharmaceuticals. earnings last quarter?▼
JNGHF earnings for the last quarter are 0.03 USD per share, whereas the estimation was 0.04 USD resulting in a -32.43% surprise. The estimated earnings for the next quarter are N/A USD per share.
Does Jiangsu Hengrui Pharmaceuticals. pay dividends?▼
Yes, JNGHF dividends are paid semi-annual. The last dividend per share was 0 USD. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Jiangsu Hengrui Pharmaceuticals. located?▼
Jiangsu Hengrui Pharmaceuticals. operates in the Other sector.
When did Jiangsu Hengrui Pharmaceuticals. complete a stock split?▼
Jiangsu Hengrui Pharmaceuticals. has not had any recent stock splits.